Volunteers willing to take part in the third phase of the COVID-19 Vaccine Clinical Trial may visit the Bahrain International Exhibition and Convention Centre (BIECC), where they can take the vaccine from 08:00 am to 08:00 pm, the Ministry of Health announced.
The ministry noted that the third phase of the vaccine’s clinical trial, conducted in partnership with the China-based pharmaceutical company, Sinopharm, has been approved by the National Health Regulatory Authority (NHRA).
It involves administering the inactive vaccine to the selected volunteers, to study the effectiveness of antibody production and the acquired protection against the virus.
The ministry revealed that the trial includes up to 6,000 volunteers, over the age of 18, and volunteers who have to undergo a health assessment prior to enlisting, as per the health requirements set by the approved protocols.
The inactivated vaccine is pre-qualified by the World Health Organisation and volunteers can register through the National Volunteer Platform.